Skip to content

Source filing unavailable

Q2 2012 · —
Revenue$210.17M+8.7% vs Q2 2011+7.1% vs Q1 2012
Net Income$8.51M+1,118.0% vs Q2 2011+27.2% vs Q1 2012
EPS Diluted$0.30+1,400.0% vs Q2 2011+30.4% vs Q1 2012
Gross Profit$131,896,000+9.5%
Operating Income$18,021,000+125.3%
Operating Cash Flowderived$2,276,000−90.7%
Free Cash Flowderived-$11,954,000N/M
Margins · derived
Gross margin62.8%+0.4 pt vs Q2 2011
Operating margin8.6%+4.4 pt vs Q2 2011
Net margin4.1%+3.7 pt vs Q2 2011

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2012Q2 2011Q2 2010Q2 2009
Revenue$210.17M$193.33M$178.60M$165.73M
Net Income$8.51M$699.00K$15.16M$11.23M
EPS Diluted$0.30$0.02$0.50$0.38

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR